Skip to content
Screener

ICU Medical ICUI Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$537.0MBeat by $25.5M
EPS$2.03Beat by $0.60
Revenue estimate$511.5M
EPS estimate$1.43

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$552.1M
EPS estimate$2.13

Financials

Q3 2025

Income statement

See full
Revenue$537.0M-8.9%
Gross profit$200.9M-1.9%
Operating income$13.7M+66.6%
Net income-$3.4M+89.7%
EPS (diluted)-$0.14+89.6%

Balance sheet

See full
Cash & equivalents$299.7M-4.1%
Total debt$1.4B-19.3%
Total equity$2.1B+3.8%
Total assets$4.1B-4.7%

Cash flow

See full
Operating cash flow$56.7M+57.1%
CapEx$29.1M+46.1%
Free cash flow$27.6M+70.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.96B-33.4%
Enterprise value$4.04B-30.8%
P/S1.3×-0.6×

Profitability

See full
Gross margin36.5%+3.6pp
Operating margin3.2%—
Net margin-0.3%-0.2pp
FCF margin3.5%-3.8pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.4×+0.2×

FAQ

When did ICU Medical report Q3 2025 earnings?
ICU Medical (ICUI) reported Q3 2025 earnings on November 6, 2025 after market close.
What were ICU Medical's Q3 2025 revenue and EPS?
ICU Medical reported revenue of $537.0M and eps of $2.03 for Q3 2025.
Did ICU Medical beat estimates in Q3 2025?
Revenue beat the consensus estimate of $511.5M by $25.5M. EPS beat the consensus estimate of $1.43 by $0.60.
How did ICU Medical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.9% from $589.1M a year earlier and eps grew 27.7% from $1.59.
Where can I find ICU Medical's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000883984-25-000034) and the 10-Q periodic report (0000883984-25-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.